Presenter Profile: Yeon Wook Kim, MD, PhD

Assistant Professor, Pulmonary Medicine, Seoul National University College of Medicine

ILCN: What is your presentation about?

Dr. Kim: My presentation will introduce Asia Pacific Policy Review and Engagement (ASPIRE) for Lung Cancer’s Agenda for Change in the Asia-Pacific, a collaborative document developed by experts from multiple countries. It focuses on building multisectoral coalitions to address gaps in lung cancer care, improve equity, reduce stigma, and support locally adapted solutions across the region.

ILCN: Why is this topic timely or important in 2026?

Dr. Kim: Lung cancer remains a major public health challenge in the Asia-Pacific region, where access to screening, diagnosis, and treatment varies widely. As scientific advances continue, it is increasingly important to ensure that these benefits reach patients equitably across different health systems.

Stories of Success: Equity, Stigma and Campaigning for Change

Sunday, September 13, at 16:45 KST • Room 101, Grand Ballroom, 1F

Yeon Wook Kim, MD, PhD, will discuss ASPIRE’s agenda for change in the Asia-Pacific region during the session Stories of Success: Equity, Stigma and Campaigning for Change. LEARN MORE

ILCN: How do you envision your work in this area benefiting future clinical strategies and patient care?

Dr. Kim: This work can help translate evidence into practical, locally relevant strategies. By engaging various stakeholders—including clinicians, policymakers, patient advocates, and public health experts—we can support risk reduction, screening, more timely treatment, and more patient-centered lung cancer care.

ILCN: What are you most looking forward to at the 2026 World Conference on Lung Cancer (WCLC)?

Dr. Kim: I am most looking forward to exchanging ideas with colleagues from around the world and learning from diverse regional experiences. WCLC is an important opportunity to reconnect with esteemed friends and colleagues and to strengthen collaboration across the global lung cancer community.

ILCN: What do you hope the audience will take away from your presentation?

Dr. Kim: Improving lung cancer outcomes requires more than scientific innovation alone. Multisectoral collaboration and sustained advocacy are essential to driving meaningful change for patients and communities.

Please refer to the 2026 WCLC Scientific Program for the most up-to-date schedule information.